Name | 4-[[6-(cyclohexylmethoxy)-7H-purin-2-yl]amino]-N,N-diethylbenzamide |
---|---|
Synonyms |
Cdk2 Inhibitor IV,NU6140
HMS3229E18 IN1369 |
Description | NU6140 is a selective CDK2-cyclin A inhibitor (IC50, 0.41 μM), exhibits 10- to 36-fold selectivity over other CDKs[1]. NU6140 also potently inhibits Aurora A and Aurora B, with IC50s of 67 and 35 nM, respectively[2]. Anti-cancer activity[1][2]. |
---|---|
Related Catalog | |
Target |
cdk2-cyclin A:0.41 μM (IC50) CDK1-Cyclin B:6.6 μM (IC50) CDK4-Cyclin D:5.5 μM (IC50) cdk5-p25:15 μM (IC50) cdk7-cyclin H:3.9 μM (IC50) Aurora A:67 nM (IC50) Aurora B:35 nM (IC50) |
In Vitro | NU6140 is less active on CDK1-cyclin B, CDK4-cyclin D, CDK5-p25 and CDK7-cyclin H, with IC50s of 0.41, 6.6, 5.5, 15 and 3.9 μM, respectively[1]. NU6140 increases catalytic activity of capase-9 and capase-3, causes increase in the sub-G1 apoptotic cell population[1]. |
References |
Molecular Formula | C23H30N6O2 |
---|---|
Molecular Weight | 422.52 |
Exact Mass | 422.24300 |
PSA | 96.03000 |
LogP | 4.61060 |
RIDADR | NONH for all modes of transport |
---|